glp-1 system Frontiers formulated for GLP A new Science Perspective highlights

Currently thought it is for diabetics and weight loss patients

Frequently Asked Questions Can I lose weight with just one month of semaglutide

Technology Networks recently spoke with Rees to learn more about the landscape for GLP-1 drugs, their limitations, and what this could mean for the next generation of obesity treatment

, Reekie, T

Rotate injection sites with each dose to prevent lipodystrophy, a condition where subcutaneous fat at the injection site changes texture due to repeated injections in the same location

Approved GLP-1 RAs: Indications and Administration Dulaglutide (Trulicity) (injection weekly) Type 2 Diabetes Exenatide extended-release (Bydureon bcise) (injection weekly) Type 2 Diabetes Exenatide (Byetta) (injection twice daily) Type 2 Diabetes Semaglutide (Ozempic) (injection weekly) Type 2 Diabetes Liraglutide (Victoza, Saxenda) (injection daily) Obesity and Type 2 Diabetes, Respectively Lixisenatide (Adlyxin) (injection daily) Type 2 Diabetes Semaglutide (Rybelsus) (taken by mouth once daily) Obesity Semaglutide (Wegovy) (injection weekly) Obesity Tirzepatide* (Mounjaro, Zepbound)(injection weekly) Type 2 Diabetes and Obesity, Respectively View the FDAs up-to-date list of approved GLP-1 RAs Cardiovascular Risk Reduction Benefits of GLP-1 RAs for Patients with T2D 2 to 4 times more likely to develop cardiovascular disease (CVD) than those without T2D